Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 20 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.53 Insider Own20.26% Shs Outstand21.84M Perf Week-7.80%
Market Cap74.91M Forward P/E- EPS next Y- Insider Trans16.29% Shs Float17.41M Perf Month0.59%
Income-23.72M PEG- EPS next Q-0.41 Inst Own3.03% Short Float3.58% Perf Quarter107.88%
Sales0.00M P/S- EPS this Y-6.02% Inst Trans101.50% Short Ratio1.35 Perf Half Y247.94%
Book/sh-0.28 P/B- EPS next Y- ROA-266.70% Short Interest0.62M Perf Year62.56%
Cash/sh0.38 P/C9.06 EPS next 5Y- ROE-440.12% 52W Range0.82 - 5.99 Perf YTD193.16%
Dividend Est.- P/FCF- EPS past 5Y-25.01% ROI- 52W High-42.74% Beta0.34
Dividend TTM- Quick Ratio1.77 Sales past 5Y0.00% Gross Margin- 52W Low318.29% ATR (14)0.50
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM6.40% Oper. Margin0.00% RSI (14)46.53 Volatility9.77% 15.52%
Employees13 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price14.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-22.21% Payout- Rel Volume0.52 Prev Close3.54
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsMay 06 Avg Volume461.04K Price3.43
SMA20-12.68% SMA506.38% SMA20070.41% Trades Volume239,232 Change-3.11%
Jun-07-24 12:31PM
Jun-06-24 10:07AM
Jun-04-24 08:41AM
May-17-24 08:37AM
May-16-24 08:37AM
08:08AM Loading…
Apr-30-24 08:08AM
Apr-29-24 08:08AM
Apr-23-24 08:51AM
Apr-05-24 08:01AM
Mar-28-24 03:00PM
Mar-26-24 03:00PM
Mar-22-24 03:00PM
Mar-21-24 03:00PM
Mar-16-24 01:49AM
09:45AM Loading…
Mar-07-24 09:45AM
Mar-06-24 11:04AM
Mar-05-24 08:45AM
Feb-27-24 10:30AM
Feb-22-24 10:30AM
Feb-07-24 08:01AM
Jan-24-24 07:15AM
Jan-17-24 09:00AM
Jan-05-24 08:00AM
Dec-19-23 07:00AM
Dec-01-23 09:55AM
Nov-17-23 03:52PM
Nov-15-23 09:35AM
07:01AM Loading…
Nov-10-23 07:01AM
Nov-07-23 09:01AM
Oct-31-23 09:00AM
Oct-30-23 08:41AM
Oct-24-23 08:00AM
Oct-19-23 08:35AM
Oct-17-23 09:00AM
Oct-12-23 09:20AM
Oct-10-23 11:15AM
Oct-03-23 08:01AM
Sep-28-23 08:01AM
Aug-21-23 09:55AM
Aug-15-23 10:20AM
Aug-08-23 08:00AM
Jul-11-23 08:00AM
Jul-10-23 08:00AM
Jun-20-23 08:00AM
Jun-07-23 08:00AM
May-08-23 08:00AM
May-01-23 06:45AM
Apr-27-23 04:10PM
Apr-24-23 09:06PM
Apr-20-23 08:00AM
Apr-18-23 08:52AM
Apr-12-23 02:17PM
Apr-11-23 02:43PM
Mar-24-23 04:30PM
Mar-13-23 10:04AM
Mar-07-23 08:00AM
Feb-13-23 12:07PM
Jan-17-23 10:00AM
Jan-05-23 08:00AM
Dec-20-22 08:00AM
Dec-13-22 08:00AM
Dec-12-22 08:00AM
Nov-22-22 08:00AM
Nov-15-22 08:00AM
Nov-09-22 04:15PM
Nov-08-22 03:40PM
Oct-12-22 07:30AM
Oct-06-22 08:00AM
Oct-04-22 07:30AM
Sep-30-22 09:00AM
Sep-29-22 09:01AM
Sep-08-22 08:00AM
Sep-06-22 08:00AM
Aug-30-22 11:07AM
Aug-22-22 08:00AM
Aug-02-22 08:00AM
Aug-01-22 03:30PM
Jul-27-22 07:52PM
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith StanDirectorApr 25 '24Buy2.03147,492299,4091,005,060Apr 26 05:30 PM
Louie Ngar YeeDirectorApr 25 '24Buy2.0319,66539,9201,167,189Apr 26 05:33 PM
Smith StanDirectorMar 14 '24Buy1.17170,940200,000857,568Mar 15 07:11 PM
Louie Ngar YeeDirectorMar 14 '24Buy1.17170,940200,0001,147,524Mar 15 07:09 PM
Luput CristianDirectorMar 14 '24Buy1.1769,28281,060367,350Mar 15 07:08 PM
CHAOUKI STEVEN MDirectorMar 14 '24Buy1.1734,64140,53088,891Mar 18 05:34 PM
Guerrero RamiroDirectorMar 14 '24Buy1.176,9288,106319,600Mar 15 07:04 PM